Pain Measurement in Rheumatic and Musculoskeletal Diseases: Where To Go from Here? Report from a Special Interest Group at OMERACT 2018.
J Rheumatol
; 46(10): 1355-1359, 2019 10.
Article
en En
| MEDLINE
| ID: mdl-30936284
ABSTRACT
OBJECTIVE:
Establishing a research agenda on standardizing pain measurement in clinical trials in rheumatic and musculoskeletal diseases (RMD).METHODS:
Discussion during a meeting at the Outcome Measures in Rheumatology (OMERACT) 2018, prepared by a systematic review of existing core outcome sets and a patient online survey.RESULTS:
Several key questions were debated Is pain a symptom or a disease? Are pain core (sub)domains consistent across RMD? How to account for pain mechanistic descriptors (e.g., central sensitization) in pain measurement?CONCLUSION:
Characterizing and assessing the spectrum of pain experience across RMD in a standardized fashion is the objective of the OMERACT Pain Working Group.Palabras clave
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Asunto principal:
Dimensión del Dolor
/
Enfermedades Reumáticas
/
Evaluación de Resultado en la Atención de Salud
/
Enfermedades Musculoesqueléticas
/
Dolor Crónico
Tipo de estudio:
Guideline
Aspecto:
Patient_preference
Límite:
Humans
Idioma:
En
Revista:
J Rheumatol
Año:
2019
Tipo del documento:
Article